相关实验视频
Updated: May 5, 2026

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.2K
在先天性心周缺失中混合冠状动脉再血管:一个病例报告
Corey Badgett1, Andrew Winegarner1, Geoffrey Hayward1
1Department of Anesthesiology, Rhode Island Hospital, Providence, RI, USA.
The American journal of case reports
|December 19, 2024
概括
由于心脏的移位,先天性心周发育对冠状动脉旁路移植提出了手术挑战. 这一案例凸显了对完全重血管化的修改方法和多学科护理的需要.
科学领域:
- 心脏病学 心脏病学
- 胸部外科手术 胸部外科手术
- 医疗成像医学成像
背景情况:
- 先天性心周发育是一种罕见的疾病,通常会导致异常的胸内解剖学,包括心脏位.
- 这些解剖学变异可能会使标准的外科手术复杂化,例如冠状动脉旁路移植 (CABG).
研究的目的:
- 报告患有先天性部分心周发病的患者严重多血管冠状动脉疾病的病例.
- 讨论在改变胸部解剖学的情况下进行重血管化的手术挑战和管理策略.
主要方法:
- 一名48岁的男性患有急性胸痛症状,接受了诊断工作.
- 手术前的成像显示严重的冠状动脉疾病和心周部分缺失与显著的心脏位移.
- 试图进行冠状动脉旁路移植,并进行手术内修改和随后的皮肤冠状动脉干预.
主要成果:
- 该患者患有严重的多血管冠状动脉疾病和心周部分缺失,导致心脏移位.
- 标准CABG因手术无法达到的冠状动脉位而在手术内进行修改.
- 在不完全的再血管化中使用了输动脉内气球和皮肤穿冠状动脉干预.
结论:
- 与先天性心周发育相关的解剖异常可以显著干扰CABG.
- 多专业合作和量身定制的手术前规划对于管理这些患者复杂的再血管化至关重要.
相关概念视频
Cardiac Catheterization I: Pre-Procedure Overview
3.4K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.4K
Mitral Stenosis I: Introduction
1.8K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
810
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Cardiomyopathy V: Interprofessional Care
761
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761

